Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, particularly those affecting children. The company has three approved medications: LIVMARLI® (maralixibat) for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile acid synthesis disorders, and CTEXLI™ (chenodiol) for cerebrotendinous xanthomatosis. Mirum is also advancing a pipeline of investigational treatments, including Volixibat for primary sclerosing cholangitis and Fragile X syndrome, showcasing its commitment to innovative solutions in rare disease therapy.
Mirum Pharmaceuticals is seeking a Senior Manager/Associate Director to support the evaluation of potential partnering opportunities in the rare disease treatment space. The role involves proactively sourcing assets, coordinating teams, and supporting transaction execution. This position requires collaboration and a strong understanding of scientific and commercial considerations.
Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, particularly those affecting children. The company has three approved medications: LIVMARLI® (maralixibat) for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile acid synthesis disorders, and CTEXLI™ (chenodiol) for cerebrotendinous xanthomatosis. Mirum is also advancing a pipeline of investigational treatments, including Volixibat for primary sclerosing cholangitis and Fragile X syndrome, showcasing its commitment to innovative solutions in rare disease therapy.
Mirum Pharmaceuticals